Brad Hirakawa
- Molecular Biology
- Oncology
- Cardiology and Cardiovascular Medicine
- Pulmonary and Respiratory Medicine
- Epidemiology
- Co-authors
- Bart JessenYvonne WillJames T. HynesJoseph JamiesonLisa D. MarroquinJames A. DykensSashi NadanacivaShem Patyna
- Topics
- Cell death mechanisms and regulation (3 papers)Advanced Breast Cancer Therapies (2 papers)Connexins and lens biology (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Brad Hirakawa
17 papers receiving 556 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 318
- Oncology 133
- Cardiology and Cardiovascular Medicine 96
- Pulmonary and Respiratory Medicine 60
- Epidemiology 58
Countries citing papers authored by Brad Hirakawa
This map shows the geographic impact of Brad Hirakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Hirakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Hirakawa more than expected).
Fields of papers citing papers by Brad Hirakawa
This network shows the impact of papers produced by Brad Hirakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Hirakawa. The network helps show where Brad Hirakawa may publish in the future.
Co-authorship network of co-authors of Brad Hirakawa
This figure shows the co-authorship network connecting the top 25 collaborators of Brad Hirakawa. A scholar is included among the top collaborators of Brad Hirakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad Hirakawa. Brad Hirakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 63 | |
| 2 | 5 | |
| 3 | 23 | |
| 4 | 9 | |
| 5 | 23 | |
| 6 | 25 | |
| 7 | Evaluation of JAK inhibition with topical tofacitinib in an experimental autoimmune uveitis model (EAU) | 6 |
| 8 | 58 | |
| 9 | 6 | |
| 10 | Characterization of Regional RTP801 Gene Expression Within the Retina and the Concentration-Effect Relationship of PF-655, an RTP801-silencing siRNA, Following Intravitreous Administration to Diabetic Rats | 1 |
| 11 | 57 | |
| 12 | Dose-Related Gene Silencing of RTP801 With the siRNA PF04523655 in Long Evans Rat Models of STZ Induced Diabetes and Laser Induced CNV | 2 |
| 13 | 6 | |
| 14 | 171 | |
| 15 | 4 | |
| 16 | 75 | |
| 17 | 0 | |
| 18 | 32 |
About Brad Hirakawa
Brad Hirakawa is a scholar working on Ophthalmology, Pharmacology and Cancer Research, having authored 18 papers that have together received 566 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (3 papers), Advanced Breast Cancer Therapies (2 papers) and Connexins and lens biology (2 papers). The work is most often cited by research in Oncology (133 citations), Pharmacology (42 citations) and Molecular Biology (318 citations). Brad Hirakawa has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Bart Jessen, Yvonne Will, James T. Hynes, Joseph Jamieson, Lisa D. Marroquin, James A. Dykens, Sashi Nadanaciva, Shem Patyna, Niel C. Hoglen and Craig D. Fisher. Their work appears in journals such as Hepatology, Journal of Pharmacology and Experimental Therapeutics and Nature Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.